Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Forensic Genomics Market, by Application
1.4.2 Europe Forensic Genomics Market, by Product
1.4.3 Europe Forensic Genomics Market, by Method
1.4.4 Europe Forensic Genomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Europe Forensic Genomics Market by Application
4.1 Europe Criminal Testing Market by Country
4.2 Europe Paternity & Familial Testing Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Forensic Genomics Market by Product
5.1 Europe Kits & Consumables Market by Country
5.2 Europe Analyzers & Sequencers Market by Country
5.3 Europe Software Market by Country
Chapter 6. Europe Forensic Genomics Market by Method
6.1 Europe Capillary Electrophoresis Market by Country
6.2 Europe Next-generation Sequencing Market by Country
6.3 Europe PCR Amplification Market by Country
Chapter 7. Europe Forensic Genomics Market by Country
7.1 Germany Forensic Genomics Market
7.1.1 Germany Forensic Genomics Market by Application
7.1.2 Germany Forensic Genomics Market by Product
7.1.3 Germany Forensic Genomics Market by Method
7.2 UK Forensic Genomics Market
7.2.1 UK Forensic Genomics Market by Application
7.2.2 UK Forensic Genomics Market by Product
7.2.3 UK Forensic Genomics Market by Method
7.3 France Forensic Genomics Market
7.3.1 France Forensic Genomics Market by Application
7.3.2 France Forensic Genomics Market by Product
7.3.3 France Forensic Genomics Market by Method
7.4 Russia Forensic Genomics Market
7.4.1 Russia Forensic Genomics Market by Application
7.4.2 Russia Forensic Genomics Market by Product
7.4.3 Russia Forensic Genomics Market by Method
7.5 Spain Forensic Genomics Market
7.5.1 Spain Forensic Genomics Market by Application
7.5.2 Spain Forensic Genomics Market by Product
7.5.3 Spain Forensic Genomics Market by Method
7.6 Italy Forensic Genomics Market
7.6.1 Italy Forensic Genomics Market by Application
7.6.2 Italy Forensic Genomics Market by Product
7.6.3 Italy Forensic Genomics Market by Method
7.7 Rest of Europe Forensic Genomics Market
7.7.1 Rest of Europe Forensic Genomics Market by Application
7.7.2 Rest of Europe Forensic Genomics Market by Product
7.7.3 Rest of Europe Forensic Genomics Market by Method
Chapter 8. Company Profiles
8.1 General Electric (GE) Co. (GE Healthcare)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Agilent Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Illumina, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Neogen Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.6 Eurofins Scientific Group (Eurofins Discovery)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.7 Gene by Gene, Ltd.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Verogen, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.8.2.3 Acquisition and Mergers:
Unique Offerings 